Study: Disinfectant cuts down on MSRA
A study of the disinfectant Byotrol at Glasgow Royal Infirmary in Scotland shows that the sanitizer cut down on the spread of methicillin-resistant Staphylococcus aureus (MRSA) by 75 percent. Recently, a study published in Infection Control and Hospital Epidemiology underscored the danger that both patients and healthcare workers face from community-acquired MRSA, a potentially deadly, antibiotic-resistant staph infection. Byotrol could help stem the spread of the bug. “Byotrol is said to be different from other disinfectants because it leaves a film on surfaces which prevents bacteria from attaching themselves and reproducing. The bugs become exhausted and agents in the disinfectant then kill them,” reports Science Daily. Report
Comments (3) | Post a comment Rate it:
Comments
By Anonymous | Posted 5:21am | March 16, 2007
This is not a new idea. Lord Lister started the anti-bacterial era with anti-sepsis which is what the spray is. Asepsis later became paramount. The description suggests that the formation of biofilms is prevented by the spray. Could this be the avenue to lessening post-op infections?
By Anonymous | Posted 8:55am | November 26, 2007
Have a look at www.deconsafe.com There's information on nosocomial and surgical site infections.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies